This is the German Healthcare Market
Germany’s healthcare market is No. 1 in Europe by market volume, number of patients, medical technology manufacturers, and healthcare providers.
- The healthcare market in numbers
- This drives the market
- (Almost) universal health insurance coverage
- Inpatient care in Germany
- Innovation clusters as key to success
The healthcare market in numbers
Healthcare spending in Germany exceeds EUR 400 billion (2019), not including expenditure for wellness and fitness. The market has grown at a rate of 4.1 percent over the past 10 years. With more than 7.5 million employees and exports in excess of EUR 126 billion, healthcare is one of the largest economic sectors in Germany.
Healthcare Expenditure (by OECD definition) | € 400.4 billion |
Market Growth (Ø 2006-2017) | 4.1% |
Employment | 7.5 million |
Exports | € 131.2 billion |
Imports | € 109.2 billion |
Number of companies |
|
| Source: Statista, BMWK, OECD 2020 | |
This drives the market
Text, Text, Text
(Almost) universal health insurance coverage
Health insurance coverage is mandatory in Germany. Insurance premiums are shared by employers and employees. The vast majority of the population is enrolled in public health insurance plans. About 10% choose private providers. Both publicly and privately insured can choose their provider. Currently, there are 105 public and 42 private health insurance companies operating in Germany (2020).
Healthcare Insurance Coverage in Germany | © BMG, Statista 2020
Inpatient care in Germany
More than 1,900 hospitals with nearly 500,000 beds operate in Germany – not including rehabilitation or elderly care facilities. The overall number of medical hospitals is declining as smaller general hospitals close or merge with other hospitals to increase efficiency.
Key Data about German Hospitals | ||||||
| Hospitals | Beds | Cases | Medical staff (full time) | Average length of stay | Capacity utilization | |
2009 | 2,084 | 503,341 | 17,817,180 | 131,227 | 8.0 | 77.5% |
2010 | 2,064 | 502,749 | 18,032,903 | 134,847 | 7.9 | 77.4% |
2011 | 2,045 | 502,029 | 18,344,156 | 139,068 | 7.7 | 77.3% |
2012 | 2,017 | 501,475 | 18,620,442 | 142,874 | 7.6 | 77.4% |
2013 | 1,996 | 500,671 | 18,787,168 | 146,988 | 7.5 | 77.3% |
2014 | 1,980 | 500,680 | 19,148,626 | 150,757 | 7.4 | 77.4% |
2015 | 1,956 | 499,351 | 19,239,574 | 154,364 | 7.3 | 77.5% |
2016 | 1,951 | 498,718 | 19,532,779 | 158,148 | 7.3 | 77.9% |
2017 | 1,943 | 497,205 | 19,455,301 | 161,151 | 7.3 | 77.8% |
2018 | 1,925 | 498,192 | 19,392,466 | 164,646 | 7.2 | 77.1% |
| Source: Destatis 2020 | ||||||
The share of privately operated hospitals continues to rise
The share of privately operated hospitals continues to rise | © German Hospital Federation 2017
Innovation clusters as key to success
Every year companies participate in thousands of research projects with other partners from industry and scientific institutions, emphasizing Germany’s reputation as a leading environment for healthcare and life sciences. Along the entire value chain – from R&D through scale-up and production to sales and marketing – Germany is known for its outstanding capabilities, resources, and infrastructure.
Medical Technology Clusters and BioRegions
Germany is home to more than 30 specialized cluster networks focusing on medical technology. Dedicated cluster management teams help obtain funding for joint R&D projects, provide shared facilities, and organize educational training programs for their members.
Germany’s “BioRegions” are regional initiatives for the advancement of modern biotechnology. Over the past three decades, these biotechnology clusters have developed to become Europe’s leading R&D hubs. Each region specializes in particular areas and facilitates collaboration between universities, R&D institutes, and private sector companies.
